Comments

Monopar Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Monopar Therapeutics (MNPR) operate in?

Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MNPRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$32.50

-2.09-6.04%

Pre-Market: Apr 1, 7:51 PM EDT

Q4 2024 Earnings were released on Mon Mar 31st, before the market open

Monopar Therapeutics (MNPR) Forecast

News Earnings Monopar Therapeutics (MNPR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Monopar Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MNPR | Benzinga

Explore Monopar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MNPR.

Open	-
Close	-
Volume / Avg.	26.00 / 51.50K
Day Range	- - -
52 Wk Range	1.72 - 54.30
Market Cap	$198.33M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.65%
Days to Cover	1.69

Recent News

3 Momentum Stocks Soaring Into 2025 and Beyond

Investors favoring a short horizon and possessing a fair amount of risk tolerance sometimes look to stocks that have already been trending upward in an effort to capitalize on their momentum. This investment strategy

MarketBeat

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

MarketBeat Week in Review – 10/21- 10/25

Equities were mixed this week; the Dow turned lower, but the S&P and the NASDAQ finished higher. In fact, the NASDAQ hit a record high on Friday buoyed by the strong earnings report from Tesla. Overall,

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	26.00 / 51.50K
Day Range	- - -
52 Wk Range	1.72 - 54.30
Market Cap	$198.33M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.65%
Days to Cover	1.69

About Monopar Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprie...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Monopar Therapeutics (MNPR) stock?

You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.

View our list of the best stock brokerages

Who are Monopar Therapeutics (MNPR) competitors?

Other companies in Monopar Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Anika Therapeutics (NASDAQ:ANIK), Eledon Pharmaceuticals (NASDAQ:ELDN), Monte Rosa Therapeutics (NASDAQ:GLUE) and Olema Pharmaceuticals (NASDAQ:OLMA).

What is the forecast, or price target, for Monopar Therapeutics (MNPR) stock?

Monopar Therapeutics has a consensus price target of $39.29.

What is the current price for Monopar Therapeutics (MNPR)?

The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $32.5 last updated April 1, 2025 at 7:51 PM EDT.

Does Monopar Therapeutics (MNPR) pay a dividend?

There are no upcoming dividends for Monopar Therapeutics.

When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?

Monopar Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Monopar Therapeutics (MNPR) going to split?

There is no upcoming split for Monopar Therapeutics.

What sector and industry does Monopar Therapeutics (MNPR) operate in?

Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.